Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2004 Aug 2;200(3):277–285. doi: 10.1084/jem.20040165

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2004, The Rockefeller University Press

This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).

PMC Copyright notice

Figure 7. — Increase in CD4⁺CD25^high T cells in the PB of RA patients responding to anti-TNFα therapy. (A) The percentage of CD4⁺ T cells expressing CD25^high was followed in four anti-TNFα responder (dashed line) and four nonresponder (solid line) patients with RA before and after treatment. (B) Analysis of larger group of patients treated with anti-TNFα (n = 27), methotrexate alone (n = 6), and healthy controls (n = 8). CD4⁺CD25^high and (C) CD4⁺CD25^low T cells (as defined in Fig. S1 A). (D) Scatter plot showing a significant correlation between the C reactive protein and the percentage of CD4⁺CD25^high T cells before and after treatment (P < 0.001, r² = 0.5278).